Updated on: November 3, 2020
Please note: the ACC uses a January - December calendar, which is indicated in the estimated release dates below. The documents appear in order based on their estimated release date.
Document Topic | Estimated Release Date |
Practice Guidelines | |
Valvular Heart Disease (Revision) | 2020 Quarter 4 |
Hypertrophic Cardiomyopathy | 2020 Quarter 4 |
Evaluation and Diagnosis of Chest Pain | 2021 Quarter 2 |
Acute Coronary Revascularization | 2021 Quarter 2 |
Heart Failure (Revision) | 2021 Quarter 4 |
Peripheral Artery Disease | 2022 Quarter 2 |
Expert Consensus Decision Pathways | |
Heart Failure (focused update) | 2020 Quarter 4 |
Same Day Discharge After PCI | 2020 Quarter 4 |
Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or with Atherosclerotic Cardiovascular Disease | 2020 Quarter 4 |
Cardio-oncology Risk Assessment | 2021 Quarter 1 |
Treatment of ASCVD and Multiple Comorbidities | 2021 Quarter 1 |
Hypertriglyceridemia | 2021 Quarter 1 |
Health Policy Statements | |
Career Flexibility | 2021 Quarter 1 |
Performance Measures | |
Atrial Fibrillation (Focused Update) | 2020 Quarter 4 |
Data Standards | |
Heart Failure (Update) | 2021 Quarter 1 |
Appropriate Use Criteria | |
Multimodality Imaging for Stable Ischemic Heart Disease | 2021 Quarter 2 |
Non-Emergent Non-Cardiac Surgery (pre-op) | 2021 Quarter 3 |
Implantable Cardioverter Debrillator and Cardiac Resynchronization Therapy | 2021 Quarter 3 |
Competence and Training Statements | |
Advanced Training Statement in Vascular Medicine | 2021 Quarter 1 |